MedTrace Logo

Evaluation of the Hypoalgesic Effects of Transcranial Direct Current (tDCS) in Healthy Subjects

NCT04127253 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2019-10-15

No results posted yet for this study

Summary

The main objective of this research is to evaluate and quantify hypoalgesic effects caused by imagination and observation with or without the presence of transcranial direct current (tDCS) in healthy participants. The secondary objective of this research is to evaluate the possible relationships between hypoalgesic effects and different physical and cognitive variables such as the ability to generate motor mental images, mental chronometry and levels of physical activity.

Conditions

  • Pain Modulation

Interventions

DEVICE

Sooma transcranial direct current stimulation device plus Brain training tools

This group will carry out an observation training of actions and motor imagery in combination with the stimulation of the transcranial direct current.

DEVICE

Placebo Sooma transcranial direct current stimulation deviceplus Brain training tools

This group will carry out an observation training of actions and motor imagery in combination with the placebo stimulation of the transcranial direct current, where it will be acrtivo during 15 seconds and then it will be turned off during the rest of the intervention.

BEHAVIORAL

Brain training tools in isolation

This group will act as a control, they will only carry out the training of action observation and motor imagery.

Sponsors & Collaborators

  • Centro Universitario La Salle

    collaborator OTHER

  • Universidad Autonoma de Madrid

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-06-01
Completion
2020-07-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04127253 on ClinicalTrials.gov